Fate Therapeutics (FATE) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.44
-0.38
-0.33
-0.27

Details

Expected EPS
-0.292142
Actual EPS
-0.27
Surprise EPS
0.02
Surprise Percent
+7.58%

Description

Fate Therapeutics (FATE) has reported earnings of -0.27 per share for Q4 2025.

0 Comments

Share your thoughts